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Cyclin-dependent kinase (Cdk) both promotes mitotic entry (spindle assembly and anaphase) and
inhibits mitotic exit (spindle disassembly and cytokinesis), leading to an elegant quantitative
hypothesisthatasinglecyclinoscillationcanfunctionasaratchettoordertheseevents.Thisratchet
is at the core of a published ODE model for the yeast cell cycle. However, the ratchet model requires
appropriate cyclin dose–response thresholds. Here, we test the inhibition of mitotic exit in budding
yeast using graded levels of stable mitotic cyclin (Clb2). In opposition to the ratchet model, stable
levels of Clb2 introduced dose-dependent delays, rather than hard thresholds, that varied by mitotic
exit event. The ensuing cell cycle was highly abnormal, suggesting a novel reason for cyclin
degradation. Cdc14 phosphatase antagonizes Clb2–Cdk, and Cdc14 is released from inhibitory
nucleolar sequestration independently of stable Clb2. Thus, Cdc14/Clb2 balance may be the
appropriate variable for mitotic regulation. Although our results are inconsistent with the
aforementioned ODE model, revision of the model to allow Cdc14/Clb2 balance to control mitotic
exit corrects these discrepancies, providing theoretical support for our conclusions.
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Introduction
Chromosome transmission to daughter cells occurs in discrete
steps.InS.cerevisiae,thissequencebeginswithStart,followed
by budding, DNA replication and SPB duplication, mitotic
spindle assembly, anaphase, spindle disassembly and cyto-
kinesis. An orderly execution of these steps produces two
daughter cells with hereditary material identical to the parent
cell. Execution of these steps out-of-order can produce
aneuploidorinviableprogeny.Twogeneralmechanisms could
deﬁne the order of the cell cycle: dependency between steps
(each step requiring completion of the previous step), or an
independentcentraltimerthatactivateseachstepintheproper
order (Hartwell et al, 1974; Murray and Kirschner, 1989).
Under either mechanism, accuracy and ﬁdelity could be
greatly increased by extrinsic surveillance mechanisms
(checkpoints) that prevent initiation of one step until the
preceding step is complete (Hartwell and Weinert, 1989).
Cyclins and cyclin-dependent kinase (Cdk) provide
excellent candidates for a central controlling timer. In all
eukaryotes, mitotic cyclin–Cdk activity rises and falls once per
division. Mitotic cyclins (CLB1, 2, 3, and 4 in S. cerevisiae) are
required for mitotic entry (spindle assembly and anaphase).
However, overexpression of mitotic cyclin prevents mitotic
exit (spindle disassembly and cytokinesis), resulting in
telophase arrest (Surana et al, 1993). If high cyclin levels
induce mitotic entry, and mitotic exit is restrained until cyclin
level drops below a lower threshold (Murray and Kirschner,
1989; King et al, 1994; Stern and Nurse, 1996; Zachariae and
Nasmyth, 1999; Morgan and Roberts, 2002; Morgan, 2007;
Figure1A),thenoscillationofmitoticcyclinwouldobligatorily
order sequential events of mitotic entry and exit. The result is
‘ratchet’-like control of mitosis: a single rise and fall of cyclin–
Cdk activity toggles activation and inhibition of both mitotic
entry and exit, producing one and only one sequential
execution of each step. Although elegant and supported by
experimental data, this hypothesis depends critically on
quantitative values of cyclin response thresholds; the model
fails if mitotic entry can be driven by cyclin levels too low to
inhibit mitotic exit, or exit can be inhibited only by levels not
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In S. cerevisiae, oscillation of cyclin–Cdk activity is largely
a product of periodic cyclin transcription and proteolysis.
The anaphase-promoting complex (APC), bound to one of two
activators, Cdc20 or Cdh1 (Visintin et al, 1997; Yeong et al,
2000), mediates Clb proteolysis (Irniger et al, 1995). APC
Cdc20
also mediates proteolysis of the anaphase inhibitor Pds1,
promoting anaphase (Cohen-Fix et al, 1996). Subsequently,
APC
Cdh1 completes Clb2 degradation (Schwab et al, 1997;
Yeong et al, 2000). Absence of Cdc20 causes metaphase arrest
and stabilizes Clb2 (Hartwell and Smith, 1985; Sethi et al,
1991; Lim et al, 1998; Irniger, 2002; Wa ¨sch and Cross, 2002).
Mutant Clb2, lacking Cdc20 and Cdh1 recognition domains
(Clb2kd), is stable and causes a post-anaphase block when
expressed from the endogenous locus (Wa ¨sch and Cross,
2002). The latter observation supports the ratchet model, as
endogenous expression of undegradable Clb2 drives cells into
mitosis, but cells then fail to exit because this cyclin cannot be
degraded.
The stoichiometric inhibitor, Sic1, can reduce cyclin–Cdk
activity independently of cyclin proteolysis. Sic1 is normally
expressed during mitotic exit (Schwob et al, 1994). Its
overexpression can rescue normally lethal genetic back-
grounds in which mitotic cyclin degradation is blocked
(Wa ¨sch and Cross, 2002; Archambault et al, 2003; Cross, 2003;
Thornton and Toczyski, 2003). In such rescued strains, alter-
nating accumulation and proteolysis of Sic1 may substitute
for oscillating cyclin levels, periodically inhibiting cyclin–
Cdk activity and providing the rise and fall of cyclin–
Cdk activity (Thornton et al, 2004) required for viability
according to ‘ratchet’ models. Sic1 levels are periodic both
because of cyclin–Cdk-mediated proteolysis (Schwob et al,
1994; Verma et al, 1997) and periodic transcription (Knapp
et al, 1996).
The Cdc14 phosphatase is required for mitotic exit in
budding yeast (Visintin et al, 1998). From G1 phase until
mitosis, Net1 anchors Cdc14p in the nucleolus; Cdc14 is
releasedinto therest ofthecell onlyduringmitosis (Shouet al,
1999). It is then thought to promote SIC1 transcription by
dephosphorylating Swi5, the major SIC1 transcription factor,
and to promote Sic1 stability by dephosphorylating Sic1
itself (Visintin et al, 1998). Cdc14 also dephosphorylates
Cdh1, promoting its association with the APC and driving
the degradation of many proteins including mitotic cyclins
(Visintin et al, 1998). Cdc14 release from the nucleolus
depends on the FEAR pathway in early anaphase, and later
on the mitotic exit network (Shou et al, 1999; Stegmeier et al,
2002). The integration of Cdc14 release with the cyclin–Cdk
cycle is still incompletely understood.
The complete cell-cycle control system has been modeled
mathematically using systems of ordinary differential equa-
tions (Chen et al, 2004), and the efﬁcacy of this model in
accounting for many mutant backgrounds has been estab-
lished (Chen et al, 2004; Cross et al, 2005). Two subsequent
models concentrating solely on mitotic exit have also been
proposed: one to account for the regulation of Cdc14 release
from the nucleolus (Queralt et al, 2006) and another for
describing reciprocal negative regulation of Clb2 and Sic1, and
its possible consequences for mitotic irreversibility (Lopez-
Aviles et al, 2009). These latter two models do not attempt to
provide a comprehensive view of cell cycle control, but
demonstrate the plausibility of dynamic molecular mechan-
isms that may regulate mitotic exit.
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Figure1 Measurement ofthe post-anaphase response toundegradable Clb2p
in single cells. (A) Hypothetical control of mitotic order: high B-cyclin promotes
mitotic entry and inhibits mitotic exit, whereas low B-cyclin permits exit but not
entry. In this model cyclin oscillation dictates ordering. (B) Method schematic
using PGAL1-CLB2kd-YFP GAL4-rMR PMET3-CDC20 cells, with phenotypic
markers CFP–TUB1 (blue) and MYO1–mCherry (red). (1) Metaphase block;
(2) Clb2kd–YFP pulse by brief incubation with deoxycorticosterone to activate
Gal4–rMR; (3) Synchronous release to anaphase by Cdc20 induction; variation
in Clb2kd–YFP dosage affects mitotic exit; Clb2kd concentration and exit
phenotypes can be correlated. (C) Measurement of endogenous Clb2–YFP
reference levels. PMET3-CDC20 bar1D CLB2-YFP clb1,3,4D (BD141-52D)
cultures were synchronized with a-factor and released to either a metaphase
block or a second a-factor block. [Clb2–YFP] level was measured every 10min.
(D) Peak [Clb2–YFP] and steady state [Clb2–YFP] levels at metaphase arrest,
as measured in (C), deﬁne the relevant concentration ranges for the hypothetical
plot,[Clb2kd–YFP] versusprocess execution, generatedfromthe cellsdescribed
in (B). The green box illustrates a hypothetical threshold (steepest decrease,
passing through 50% completion) in units of peak [Clb2–YFP]. (E) Single cell
distribution of Clb2–YFP at peak concentration (left, BD128-37A) and of a
typical Clb2kd–YFP pulse at 60min post-release from metaphase arrest
(right, BD127-11B).
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ships between mitotic cyclin levels and the ability to carry out
multiple steps in mitotic exit. The results challenge the cyclin-
based ratchet model but can be reconciled by incorporating
Cdc14 as a general antagonist of Clb2-Cdk, directly removing
Clb2–Cdk-dependent phosphorylations that inhibit mitotic
exit. Similarly, the quantitative cell cycle model (Chen et al,
2004) that incorporates a cyclin-based ratchet as the central
determinant of mitotic entry and exit, predicts our results
poorly, but editing the model to include Cdc14 as a direct Clb2
antagonist rescues the model’s ability to match our results.
Results
Development of a method to load pre-anaphase
cells with titrated, physiological levels of
undegradable mitotic cyclin
Any ratchet model for mitotic control by cyclin–Cdk complex
must predict that high but physiological levels of mitotic
cyclin-dependent kinase activity will inhibit mitotic exit. We
developed a method to introduce a ﬁxed level of a stable
version of the major mitotic cyclin, Clb2, before anaphase
(Figure 1B). In the absence of degradation, Clb2 expressed
from its endogenous promoter accumulates above its normal
peak level attained in cycling cells (Figure 1C); this is also true
of Clb2kd expressed from its endogenous promoter (data not
shown). Therefore, completely blocking Clb2 degradation
results in a super-physiological level of cyclin. To study the
ability of undegradable Clb2 at physiological levels (i.e. at or
aroundnormalpeaklevels),weinducedapulseofﬂuorescent,
undegradable Clb2 (Clb2kd–YFP) (Wa ¨sch and Cross, 2002)
expression from the GAL1 promoter using a transient pulse of
deoxycorticosterone in cells containing a hormone-responsive
Gal4–rMR fusion (Picard, 2000; Supplementary methods;
Supplementary Figures 1–8). The resulting Clb2kd pulse
remained stable throughout subsequent release from a
metaphase cdc20 block (Supplementary Figure 1C). CLB2–
YFP at the endogenous locus was fully functional (Supple-
mentary Figure 2), indicating that the YFP tag did not
signiﬁcantly affect Clb2 function.
We measured Clb2kd concentration in ‘peak-equivalent’
units, where one peak-equivalent is the average peak Clb2
level observed in a synchronous cell cycle (Figure 1C). In this
study, we have not calibrated peak Clb2 level in absolute
terms; previous results suggest a value around 3000 molecules
per cell (Cross et al, 2002). Clb2–YFP levels measured by
immunoblotting in a-factor-synchronized cultures were iden-
tical with or without Cdc20 expression up to the time of peak
accumulation (60min post-release); thereafter these levels
diverge (Figure 1C; Supplementary Figures 3 and 4). As the
peak level and timing are probably dependent on activation of
Clb2p degradation by APC
Cdc20 (Yeong et al, 2000), this result
indicates that the 60-min peak closely approximated the
average single-cell peak (Supplementary Figure 3). We used
cdc20-depleted cells released for 60min, followed by a 45-min
incubation in cycloheximide, to obtain a distribution of Clb2–
YFP ﬂuorescence in cells at the time of peak expression. (The
incubation in cycloheximide was required to allow maturation
of Clb2–YFP ﬂuorescence; cdc20 depletion was required to
preventClb2–YFP degradationduring this interval; Figure 1E).
Detailed analysis of quantitative immunoblotting measure-
ments andaveragedsingle-cell ﬂuorescence measurements for
Clb2–YFP and Clb2kd–YFP levels show a close agreement
between the two methods, indicating that we can accurately
estimate Clb2kd–YFP levels in peak-equivalent units in single
cells (Supplementary Figure 1D).
Timing and magnitude of peak Clb2–YFP concentration in
this procedure were the same in the presence or absence of the
other mitotic cyclins CLB 1, 3, or 4 (Supplementary Figure 2).
This leads to the important conclusion that ‘peak-equivalent’
Clb2 is a physiologically meaningful level; it provides
sufﬁcient mitotic cyclin for timely induction of mitotic entry.
These measurements are consistent with the original char-
acterization of clb1, 3, and 4D cells that remain fully viable
with near-normal cell cycle kinetics (Fitch et al, 1992). Our
protocol generated a unimodal distribution of single-cell
Clb2kd–YFP levels in cdc20-blocked cells that was similar to
the distribution observed for peak wild-type Clb2 (Figure 1E).
Single-cell measurements of inhibition of mitotic
exit events by graded levels of undegradable
mitotic cyclin
On release from the metaphase block, endogenous Clb2 was
completely degraded, regardless of Clb2kd level (Supplemen-
tary Figure9),suggestingthat mitoticcyclinsClb1,3, and4are
also degraded (Baumer et al, 2000). Furthermore, simulta-
neous deletion of CLB1, 3, and 4 did not affect the Clb2kd
dose–response curves (Supplementary Figure 10). Thus, it is
unlikely that endogenous mitotic cyclins are confounding our
analysis.
We were surprised at the efﬁciency of degradation of
endogenous Clb2 under these conditions, as this degradation
probably requires Cdh1. Cdh1 is inactivated by cyclin–Cdk
complex (Zachariae et al, 1998), and so might be expected
to be inactive in the presence of high Clb2kd. It is possible
that Clb2–Cdk complex is inefﬁcient at inhibiting Cdh1,
compared with Clb5 or G1 cyclin–Cdk kinases (Yeong et al,
2001).
We correlated Clb2kd–YFP levels in individual cells to
mitotic exit events, including spindle disassembly, initiation
of bud ring contraction, completion of cytokinesis, and new
bud formation (Figure 2A and B). These data allowed us to
generate inhibitory concentration curves for each event.
Although strong overexpression of stable Clb2 was reported
to block spindle disassembly (Surana et al, 1993), a culture
pulsed with an average of peak-equivalent Clb2kd only
delayed spindle disassembly for B15min (Figure 2B and C).
In single cells, persistence of long spindles at 45min post-
release required about two peak-equivalents of Clb2kd
(Figure 2D), and by 60min, even cells with very high Clb2kd
levels had disassembled spindles (Figure 2C).
High-dose Clb2kd (42 peak-equivalents) stably blocked
cytokinesis and rebudding. In contrast, one peak-equivalent
of Clb2kd delayed but did not block these events; cells
slowly constricted their Myo1 rings and frequently formed
new buds before completing cytokinesis (budding almost
never occurs before completion of cytokinesis in unpulsed
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with the following observations. First, levels of Clb2kd
that inhibited cytokinesis and rebudding were similar (1–2
peak-equivalents). Second, these inhibitory levels increased
over time at different rates (Figure 2D); by 60min post-release,
rebudding could occur at a Clb2kd level that still inhibi-
ted completion of cytokinesis. Strongly delayed cytokin-
esis was directly observable by time-lapse microscopy of
Clb2kd-pulsed cells, as was the occurrence of bud formation
before completion of cytokinesis (Supplementary Movies
1 and 2).
These results suggest that the maximal Clb2 concentration
attained during a normal cell cycle cannot stably block mitotic
exit. Furthermore, Clb2 inhibition of mitotic exit does not
reﬂect a discrete threshold, but rather dose-dependent delays
that are process-speciﬁc. Spindle disassembly is least sensitive
to Clb2kd level, followed by onset of cytokinesis, rebudding,
and completion of cytokinesis.
The high level of Clb2kd needed to inhibit rebudding
suggests that cells can commit to a new division cycle without
reducing Clb2 concentration below peak or without complet-
ing cytokinesis. Consistent with this idea, inhibition of SPB
duplication after anaphase required at least 1–2 peak-
equivalents of Clb2kd, as suggested by comparison with
cytokinesis in Clb2kd–YFP-pulsed cells (Figure 3A and B;
Supplementary Figure 11). The high requirements for Clb2
inhibition of mitotic exit events compared to normal peak
levels suggest that, in a normal cell cycle, Clb oscillation
may not sufﬁce to explain why these processes occur in
sequence and without repetition. A stable block to mitotic exit
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Figure 2 Peak-equivalent undegradable Clb2 permits mitotic exit. Cells (BD127-11B) pulsed with Clb2kd–YFP were collected at 15-min intervals after release from
metaphase block. (A) CFP–TUB1 and MYO1–mCherryallow monitoring of anaphase spindle disassembly, initiation and completion of actomyosin ring contraction, and
new bud formation. (B) Representative images with or without the Clb2kd–YFP pulse. For pulsed cells, merged Myo1–mCherry and CFP–Tub1 images are shown
above (image processing for readability as described in Supplementary methods), Clb2kd–YFP below. White arrows indicate cells that rebud before completing
cytokinesis. (C) Anaphase spindles versus time post-release plotted for pulsed and unpulsed cultures. Average [Clb2kd–YFP] level dilutes from 150 to 100% peak after
60min (Supplementary Figure 1c) because of increase in cell mass. (D) Mitotic exit events (A) versus [Clb2kd–YFP] level (as schematized in Figure 1C), at 15-min
intervals post-release. Unpulsed cells have completed cytokinesis and rebudded by 60-min post-release. As spindle disassembly is completed in nearly all pulsed cells
by 60min post-release (C), spindle disassembly versus [Clb2kd–YFP] level was only measured at 45min. Color scheme for plots is as in Figure 2A.
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normal cell cycle.
Abnormalities in the second cycle after mitotic exit
in the presence of undegradable Clb2
Intriguingly,incellswithmoderatelyhighClb2kdlevel(Xone-
half peak-equivalent), the duplicated SPBs did not nucleate a
normal metaphase spindle in the succeeding cell cycle
(Figure 3A and B; Supplementary Figure 12)—a spindle-like
tubulin structure formed that was attached to only one of the
two SPBs (Figure 3C and D; Supplementary Figure 13). In
addition, similarly low Clb2kd concentrations abrogated
mating factor arrest. Control-unpulsed cells released into
mating factor exited mitosis and then arrested without buds or
separated SPBs (Figure 4A), whereas cells pulsed with low
levels of Clb2kd rebudded (Figure 4B; Supplementary
Figure 14), activated the CLN2 G1 cyclin promoter
(Figure 4C), and duplicated and separated SPBs, despite the
presence of mating factor (Supplementary Figure 15). These
ﬁndings suggest apreviously unsuspected rationale for mitotic
cyclin degradation: even if mitotic cyclin levels are not high
enough to block mitotic exit, cells that do exit exhibit multiple
defects in the succeeding cell cycle.
Pulsed Clb2kd is associated with constant histone
H1 kinase activity through mitotic exit, and does
not display signiﬁcant regulation by Swe1 or Sic1
Thus far, we have measured the effect of mitotic cyclin
concentration on mitotic exit. As cyclins affect cellular
processes by activating Cdk, it was important to determine
whether our Clb2kdpulses generate an equivalentlevel of Cdk
activity. Therefore, we tested the effects of known Cdk
inhibitors, Swe1 and Sic1 (Booher et al, 1993; Schwob et al,
1994), on the Clb2kd dose–response relationships described
above,andalsodirectlymeasuredtheinvitroClb2–Cdkkinase
activity generated throughout our protocol.
Swe1, the homolog of the Wee1 Cdk-inhibitory kinase, has
the potential to downregulate Clb2kd–Cdk activity. However,
deletion of Swe1 did not signiﬁcantly alter the Clb2kd dose–
response curves (Supplementary Figure 16). For this reason,
we assume that Swe1 did not limit Clb2kd–Cdk activity under
the conditions of our assay. This assumption is consistent with
the ﬁnding that Swe1 is degraded during mitosis and does not
reaccumulateuntilbudemergenceinthesubsequentcycle(Sia
et al, 1998).
Sic1 is another prominent candidate for limiting Clb2kd–
Cdk activity (see Introduction section). SIC1 deletion resulted
in many aberrant/inviable cells even without a Clb2kd pulse
(Nugroho and Mendenhall, 1994; data not shown), preventing
the use of sic1D cells for reliable assignment of phenotypes to
undegradable cyclin. Therefore, we evaluated the role of SIC1
in limiting Clb2kd–Cdk activity by examining the effects of
increases in SIC1 gene dosage. Interpretation of these experi-
mentsreliesonknowncharacteristicsofSic1–Clb2interaction.
Sic1 stoichiometrically binds Clb2–Cdk complexes, removing
them from the active pool. We reasoned that if Clb2kd
thresholds for inhibiting mitotic exit were set by exceeding a
Sic1 blockade, then doubling Sic1 expression levels should
sharply increase these thresholds.
In contrast, there are two possible reasons why doubling
Sic1 expression might have little or no effect on the thresholds.
First, Sic1 levels may not rise high enough to signiﬁcantly
inhibit near-peakClb2—the relativelevelsaredirectly relevant
since Sic1 is a stoichiometric inhibitor. Peak Sic1 levels in
cycling cells were previously estimated to be less than peak
Clb2 levels (Cross et al, 2002). Second, Clb2–Cdk complex
phosphorylates Sic1, promoting its degradation, and Clb2 can
also phosphorylate and inactivate Swi5, the main SIC1
transcription factor. Therefore, persistent Clb2kd–Cdk activity
may prevent signiﬁcant Sic1 accumulation, in which case
doublingSiclexpressionmayhavelittleeffectonClb2kddose–
response thresholds.
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Figure 3 Persistent Clb2 after mitotic exit causes aberrant spindle assembly in
the next cell cycle. (A) SPB duplication and separation (red, top, BD144c-8B) or
metaphase spindle formation (red, bottom, BD127-11B) are plotted with
completionofcytokinesis(gray)versustimepost-releasefromcdc20arrestforan
unpulsed control and a low Clb2kd YFP pulse (70% peak at the beginning of the
experiment, diluting to 40% peak by the end). (B) To the right of each graph are
ﬂuorescence microscopy images of cells 90min post-release: Myo1–mCherry
merged with Spc29–CFP (top) or CFP–Tub1 (bottom). For Spc29–CFP, cells
with one, two, or three SPBs are indicated (arrows). For CFP–Tub1, arrows label
cells with bar-shaped metaphase spindles (red), unipolar spindles (green) or
short discontinuous ‘2-dot’ spindles (blue). (C) Spindle morphology versus
Clb2kd–YFP concentration among cells that have completed cytokinesis at
90min post-release. Phenotypes charted are described in (B, bottom). (D) Cells
bearing CFP–Tub1 and Spc29–YFP (YL178-1-12-2) were pulsed with untagged
Clb2kd and released for 90min from cdc20 arrest. Three spindle types are
shown: (1) One dim SPB distant from DAPI staining that does not colocalize with
tubulin (top), (2) two SPBs with discontinuous tubulin arrays (bottom), or (3) a
normal bipolar spindle (bottom).
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cytokinesis to Clb2kd dosage. Indeed, sensitivity was only
moderately decreased by 6 SIC1 (Figure 5B).
When we examined second-cycle responses to Clb2kd,
which occurred at sub-peak Clb2kd levels, such as failure of
SPB duplication or failure of mating-factor arrest, (see above),
the 2 SIC1 cassette clearly decreased sensitivity to Clb2kd
(Figure 5C). This resultconﬁrmed that the increased SIC1 gene
dosagecouldyieldincreasedSic1proteinwith thecapabilityof
inhibiting Clb2kd in our protocol. This increased Sic1 pro-
duction was presumably overwhelmed by titration and/or
degradationwithhigher(near-peak)Clb2kdlevels,accounting
for the identical inhibitory dose–response of cytokinesis to
Clb2kd in 1 SIC1 and 2 SIC1 backgrounds (Figure 5B).
0′ 75′
N
o
 
p
u
l
s
e
+
 
C
l
b
2
k
d
p
u
l
s
e
CLN2pr-GFP
Time post-release
0% 100% 200%
0%
50%
100%
%
C
e
l
l
s
[Clb2-YFP]
60′ post-release Pulse + α-factor
0′ 20′ 40′ 60′
0%
50%
100%
%
C
e
l
l
s
Time:
No pulse + α-factor
Complete cytok 
Partial cytok 
Rebudded
α-Factor arrest
A
C
B
Figure 4 Persistent Clb2 after mitotic exit eliminates G1 mating factor sensitivity. A bar1D strain (BD127b-9D) was released from cdc20 arrest into a-factor-containing
medium (A) without or with (B) a Clb2kd–YFP pulse. Merged YFP, mCherry, and DIC channels are shown. Unbudded cells (black), complete (red) or partial (blue)
cytokinesis, and rebudding (green) are plotted versus time post-release for unpulsed cells (A) or versus Clb2kd–YFP concentration 60-min post-release for pulsed cells
(B). (C)Cells bearing Myo1–mCherry andGFP fused tothe Cln2 degron under the control ofthe CLN2 promoter (BD143a-21C) were released from cdc20 arrest into a-
factor-containing medium with or without a pulse of untagged Clb2kd. Merged GFP, mCherry and DIC channels are shown at 0 and 75min post-release.
Unpulsed
+ Clb2kd pulse
(~1.5× peak)
A
n
t
i
-
G
F
P
40′ 30′ 10′ 0′ 50′ 90′ 70′ 60′ 80′ 20′
Peak
Clb2-YFP
Clb2kd-pulsed
peak Sic1-GFP
Unpulsed
peak Sic1-GFP
1.0 1.2 0.56
Anti-GFP
Anti-Pgk1
Sic1-GFP
Time post-release:
[Clb2kd-YFP] (% peak)
Unbudded arrest 
0%
100%
200%
0%
50%
100%
%
C
e
l
l
s
[Clb2kd-YFP] (% peak)
Cytokinesis
0%
100%
200%
0%
50%
100%
%
C
e
l
l
s
0
2
4
6
0 2 04 06 0
SIC1 mRNA A
DE
BC
Time post-release
F
o
l
d
 
e
x
p
r
e
s
s
i
o
n
(
1
 
=
 
p
e
a
k
 
W
T
)
 
1× SIC1  2× SIC1  6× SIC1 
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2 SIC1 (BD138a-5), and 6 SIC1 (BD138a-1) cells pulsed with Clb2kd–YFP. (C) Mating factor arrest versus [Clb2kd–YFP] level at 60min post-release in SIC1
WT
(BD127b-9D), 2 SIC1 (BD138a-5), and 6 SIC1 (BD138a-1) cells pulsed with Clb2kd–YFP. (D, E) Peak SIC1–GFP is less than peak CLB2–YFP and this is
decreasedfurtherinpulsedcells.CellsbearingSic1–GFP(YL205-7-5-4)werereleasedfrommetaphasearrest(MET-CDC20)withorwithoutanuntaggedClb2kdpulse,
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normalizing to wild-type peak SIC1–GFP.
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experiments, we examined Sic1 accumulation in our protocol
with or without a Clb2kd pulse. Sic1–GFP accumulation was
transient with or without the pulse, but pulsed cells
accumulated an approximately two-fold lower level of Sic1
(Figure5DandE).Asnotedabove,thiscouldbeduetoClb2kd-
mediated Sic1 degradation or due to Clb2kd-mediated inhibi-
tion of SIC1 transcription, or both. In either case, this ﬁnding
could explain why increasing SIC1 gene dosage does not affect
the thresholds. Importantly, this result is observed with only a
single endogenous copy of tagged SIC1.
Parallel immunoblotting using anti-GFP antibody against
peak Sic1–GFP and peak Clb2–YFP (wild-type Clb2 from a
synchronous time course, as in Figure 1C) showed that peak
Clb2–YFP is probably higher than peak Sic1–GFP when
standardized to total cell protein (Figure 5E). This quantitative
comparison is preliminary; comparing the abundance of
proteins of different molecular weight is not trivial, and
careful titration of the quantiﬁcation by serial dilution of
all samples and standards has not been carried out. Never-
theless, it suggests that peak Sic1 cannot completely titrate
peak Clb2, leaving APC activators, Cdc20 and Cdh1, as
primary regulators Clb2–CDK activity. Both conclusions
corroborate previous analyses using different methods (Cross
etal,2002;Wa ¨schandCross,2002).AsthelevelofSic1–GFPin
Clb2kd-pulsed cells was even lower, it is unlikely that
sufﬁcient Sic1 can accumulate to inhibit peak-equivalent
Clb2kd–CDK activity.
To conﬁrm directly that neither Swe1 nor Sic1, nor any
other inhibitor, signiﬁcantly inhibited Clb2–Cdk kinase
activity in our experiments, we measured Clb2-associated
protein kinase activity in vitro. In control unpulsed 1 SIC1
(i.e. wild-type) cells, wild-type Clb2 protein and associated
in vitro histone H1 kinase activity were completely elimina-
ted 30min after release from the cdc20 block. In contrast,
in Clb2kd-pulsed 1 SIC1 and 2 SIC1 cells, kinase activity
of a sub-peak-equivalent level of Clb2kd remained constant
throughout the time-course (Figure 6A). 6 SIC1 caused
brief inhibition of Clb2kd-associated kinase 30min after
release, correlating with the modest effect of 6 SIC1 on
cytokinesis. Clb2-associated kinase activity per unit protein
was similar for Clb2kd and wild-type Clb2 (Figure 6A). Thus,
peak-equivalent Clb2kd–Cdk activity is constant throughout
our protocol.
Mcm2 nuclear transport as a biosensor for in vivo
Clb2kd kinase activity
The MCM complex, required for pre-replicative complex
formation at DNA replication origins, is excluded from the
nucleus by Clb-dependent phosphorylation (Labib et al, 1999;
Nguyen et al, 2000). Using time-lapse microscopy to detect
Mcm2–GFP fusion expressed from the endogenous locus, we
observed sharp nuclear accumulation of Mcm2 shortly after
the release of the cdc20 block in cells not pulsed with Clb2kd
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Mcm2 nuclear accumulation; the dose–response data sug-
gested that even sub-peak Clb2kd levels were able to
substantially limit Mcm2 nuclear accumulation. This in vivo
ﬁnding conﬁrms the conclusions reached above that pulsed
Clb2kd-associated kinase activity is constitutive in our
protocol.
Cdc14 is released from the nucleolus on schedule
independently of Clb2kd levels, providing
a possible mechanism to allow mitotic exit in the
presence of high levels of undegradable Clb2
Cdc14, a phosphatase that reverses Cdk-mediated phosphor-
ylation, is required for mitotic exit in budding yeast (Visintin
et al, 1998). Although the results above indicate that the
known functions of Cdc14 in activating Sic1 or Cdh1 do not
contribute to mitotic exit in Clb2kd-expressing cells, Cdc14
may reverse many other Cdk-mediated phosphorylations
(Irniger, 2002; Wa ¨sch and Cross, 2002; Sullivan and Morgan,
2007). Thus Cdc14 may directly antagonize Clb2 inhibition of
mitotic exit, without affecting Clb2-associated kinase activity.
From G1 until mitosis, Net1 anchors Cdc14p in the
nucleolus; Cdc14 is released into the rest of the cell only
during mitosis (Shou et al, 1999). Using a quantitative assay
for Cdc14 release based on co-localization of Cdc14–YFP with
Net1–mCherry (Figure 7A; Lu and Cross, 2009), we observed
efﬁcientCdc14releaseinallpulsedcells,evenincellsexpected
to contain super-peak-equivalent levels of Clb2kd based on
blocks of cytokinesis and rebudding (Figure 7B). Quantiﬁca-
tion of the kinetics and amplitude of this Cdc14 release event
revealed no relationship with Clb2kd levels (data not shown;
Y Lu and FRCross, in preparation). Thus, the balance between
Clb2–Cdk activity and released Cdc14 phosphatase may be the
relevant variable in ordering mitotic events (Figures 7C and
D). In agreement with this model, extra copies of CDC14
rescued the viability of heterozygous CLB2kd/CLB2 diploids
(CLB2kd and CDC14 under endogenous promoters)
(Figure 7E).
The timing of partial Mcm2–GFP re-accumulation in the
nucleus in cells containing low levels of Clb2kd (Figure 6D)
was approximately coincident with the timing of Cdc14
release, consistent with the idea that localization of the
Mcm complex is controlled by a balance between Clb2-
dependent phosphorylation and Cdc14-dependent depho-
sphorylation. However, we do not have direct bioche-
mical evidence that Cdc14 dephosphorylates Mcm proteins,
and the relationship between Cdc14 activity and Mcm
relocalizationmaynotbestraightforward(BraunandBreeden,
2007).
We noted that eventual mitotic exit in Clb2kd-pulsed
cells was frequently signiﬁcantly delayed after the initial
Cdc14 release event, whereas mitotic exit in unpulsed con-
trols is nearly coincident with Cdc14 release. This delay
could reﬂect dilution of Clb2kd concentration as cells grow;
we have also observed additional cycles of Cdc14 release
under these conditions, which could contribute to ultimate
mitotic exit in these experiments (Y Lu and FR Cross, in
preparation).
A previous computational model accounts poorly
for the quantitative dose–response relationship
between Clb2kd and mitotic exit
Chen et al. have presented a model that formalized the cell
cyclecontrolnetworkasasetofordinarydifferentialequations,
integrating many experimental results. In this model, the
criterion for cell division (mitotic exit) is the reduction in the
active Clb2 level below an inhibitory threshold KEZ.
This model was not accurate in simulation of our results
(Figure 8A and B), whether we substituted initiation or
completion of cytokinesis from our experimental results for
model-predicted cell division. The model predicted signiﬁ-
cantly greater Clb2kd-induced delays than the measured
values. Most importantly, modeling a doubling of SIC1 dosage
strikingly reduced the simulated delay per unit Clb2kd,
whereas it had little effect on the actual delay (Figures 5B
and 8B); doubling SIC1 dosage was also predicted to result in a
striking decrease in Clb2kd-associated kinase activity on
mitotic exit, in contrast to our experimental results (Figures
6C and 8D).
For simulated exit to occur in the model, Clb2 activity must
be reduced below a hard threshold; activity of undegradable
Clb2 can only decrease in the model due to Sic1 inhibition.
Thus, this model is structurally unable to account for our
results, because at a near-inhibitory Clb2 level, doubling SIC1
expression will necessarily sharply increase the threshold for
inhibition, in contrast to the observation. The error in
prediction of the Clb2kd-associated kinase activity comes
from the same source.
Simple revision of the computational model to
allow direct Cdc14–Clb2 antagonism greatly
increases concordance of the model with
quantitative characterization of Clb2kd mitotic exit
inhibition
In the model, Cdc14 inactivates Clb2 only indirectly, through
activation of the inhibitors Sic1 and Cdh1 (and also Cdc6 as a
minor inhibitor). We hypothesized above that Clb2 kinase–
Cdc14 phosphatase balance controls mitotic exit (Figure 7C
and D). To conservatively reﬂect this idea in the model, we
altered the ‘exit criterion’. Instead of requiring active Clb2 to
drop below a threshold KEZ, we altered the model such
that mitotic exit would occur when the quantity (Clb2–
(k Cdc14)) dropped below a threshold KEZ, where k is a
parameterization of the strength of Cdc14 relative to Clb2.
Independent evidence suggests that the original model may
overexpress SIC1 (Supplementary Information); we suggest
that a four-fold reduction in SIC1 expression is reasonably
justiﬁed on biochemical and genetic grounds (Supplementary
Figure 18), and we incorporate this change in our model
revision.
Finally, we systematically varied the strength parameter k
and the exit threshold KEZ to obtain an improved ﬁt between
the revised model and our experimental data relating Clb2kd
levels and delay in mitotic exit (Figure 8B). The revised model
has a strength parameter k of 1.5 (putting Cdc14 on the same
order of activity as Clb2) and an increased KEZ (from 0.3 to
0.6; necessary to rescale because of reduction of overall
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acceptably at wild-type SIC1 levels, and importantly, shows
essentially no sensitivity to doubling of SIC1 gene dosage,
and only a moderate response to 6 SIC1, as observed ex-
perimentally (Figure 5B), and in contrast to the original model
(Figure 8B and D).
The revised model has essentially no effect on the timing of
accumulation of cell cycleregulators and cell cycle events with
otherwise ‘wild-type’ parameters, compared with the original
model (Figure 8C; Supplementary Figure 19; Supplementary
Information), and the revision signiﬁcantly improved accu-
racywithrespecttoanumberofgeneticresultsnotavailableat
the time of the original model’s generation (Supplementary
Figures 18 and 20; Supplementary Information).
We could also use the original and revised models to
reconstruct predicted kinase activity curves through our
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data in Figure 6A). We observed major errors in the original
model due to excessive Sic1 inhibition of the modeled kinase
activity; in contrast, we observed a striking correlation bet-
weenthekinaseactivityproﬁlesimulatedbytherevisedmodel
and the empirical results (Figure 8D). We emphasize that the
latter ﬁnding was an ‘unselected’ consequence of the model
revision.
Wa ¨sch and Cross (2002) observed that mitotic exit
could occur efﬁciently in the absence of Cdh1 and Sic1 (Wa ¨sch
and Cross, 2002). In those experiments, Clb2-associated
kinase was essentially constant at a moderate level, through-
out mitotic exit. The model of Chen et al (2004) predicts a
sharp approximately eight-fold downregulation of Clb2-
associated kinase in cdh1 sic1 cells, mediated by hypothetical
Cdc6inhibition;therevisedmodelgivesamuchmoreaccurate
prediction of at most a 40% reduction in Clb2-associated
kinase level in cdh1 sic1 cells undergoing mitotic exit (data not
shown). This contrast is especially pertinent in the present
context, as mitotic exit in cdh1 sic1 cells was absolutely
dependent on Cdc14 release (Wa ¨sch and Cross, 2002).
We emphasize that this model revision is only a sketch of a
solution, as we did not attempt to evaluate the revised model
with respect to all the constraining genetic and biochemical
information used to construct the original model; indeed, we
have already observed that the revised model is less effective
in some such cases than the original (Supplementary Infor-
mation). However, the revisions we suggest are simple, empi-
rically justiﬁed on independent grounds, and provide an
excellent ﬁt to our highly quantitative data set. For these
reasons,wethinkthatourmodelingresultsprovidetheoretical
support for our conclusions, and could guide further model
evolution.
Discussion
Here we have quantitatively tested a hypothesis regarding the
control of the cell cycle by cyclin–Cdk complexes (Murray and
Kirschner, 1989; King et al, 1994; Stern and Nurse, 1996;
Zachariae and Nasmyth, 1999; Morgan and Roberts, 2002;
Morgan, 2007), which suggests that oscillation of cyclin locks
mitotic entry and exit events into a speciﬁc order. We found
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Figure 8 Computational modeling of mitotic exit in the presence of undegradable Clb2p with or without direct Cdc14 antagonism. (A) Measured intervals from spindle
elongation to initiation (blue) or completion (red) of cytokinesis. At 15-min intervals after release, the Clb2kd concentration, that yielded 50% event execution, is plotted
againstthe time from 50%spindle elongation in the culture (this isthe sameexperiment aspresentedin Figure 2C andD,withthe data extracted in thisdifferent manner
to allow direct comparison with the computational model). Initial Clb2kd concentrations were extrapolated from B33% decay over 90min (Supplementary Figure 1c).
(B–D) Simulations of the cdc20-block Clb2kd-pulse protocol (Figure 1B) using either the standard ODE model published by , or a revised model in which Cdc14 directly
opposes Clb2 to promote mitotic exit (the criterion for mitotic exit in the original model, Clb2 – KEZ¼0, with KEZ¼0.3, was altered to Clb2 – (1.5 Cdc14) – KEZ0¼0,
with KEZ¼0.6). SIC1 expression was also reduced four-fold by decreasing basal and regulated SIC1 synthesis parameters (details of the simulation and revised model
in Supplementary Information). The threshold for initiation of DNA replication was increased from 1 to 5 for reasons detailed in Supplementary Information. The model
was implemented in MATLAB code revised from that described in Chen et al (2004) to explicitly take account of the cdc20 block-release protocol. For comparison with
experimental data, ‘spindle elongation’ was arbitrarily taken to occur 10min after reactivation of CDC20 synthesis. In all other respects, the original and revised models
are identical. Code can be made available on request. (B) Initial Clb2kd concentration versus simulated intervals from ‘spindle elongation’ to mitotic exit (compare with
Figure 6A), using both the standard (left) and revised (right) models. 1 ,2 , and 6 SIC1 simulations are plotted (blue, green, and red, respectively); these were
generated by multiplying the SIC1 synthesis parameters by 1, 2 or 6. (C, D) Clb2 protein (green) and kinase activity (red) in peak-equivalent units, simulated with the
standard (top) and revised (bottom) models. Compare with experimental data in Figure 4C. (C) Clb2
WT protein without the Clb2kd pulse. (D) Peak Clb2kd pulse
simulations in 1 ,2 , and 6 SIC1 backgrounds.
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on mitotic exit (Figure 2D), rather than a single all-or-none
threshold; importantly, signiﬁcant delays in any process may
require non-physiological Clb2 levels. Our measurements
suggest that additional regulation, beyond Clb–Cdk inhibition
ofmitotic exit, isnecessary tofullyexplain theorderof stepsin
the cell cycle. Cdc14 release could provide a major counter-
balance, even to high Clb–Cdk activity, by direct depho-
sphorylation of Clb–Cdk substrates. Introducing this modi-
ﬁcation to a previous theoretical treatment of control of the
budding yeast cell cycle may strongly improve the model’s
ability to simulate our quantitative results.
The counterbalance between Cdc14 and CIp–Cdk could be
substrate-speciﬁc, based on differential afﬁnities. This could
explain different Clb2kd dose-responsiveness for different
mitotic exit events. Mcm2–GFP nuclear re-accumulation, for
example, seems highly sensitive to Clb2kd levels, compared
with spindle disassembly, cytokinesis and rebudding. Too few
relevant phosphorylation/dephosphorylation substrates have
been identiﬁed to begin testing the biochemical basis for these
differences.
Subcellular localization of key regulators could also be
important. Clb2 and released Cdc14 are concentrated in the
nucleus, spindle pole bodies and bud neck (Figures 2B and
7A). If local levels of Clb2 and Cdc14 deviate over time from
their global oscillation, then measurements of whole-cell
activity could be misleading. Oscillation of the Cdk/Cdc14
balance near their relevant substrates may coordinate mitotic
entry and exit events (Sullivan and Morgan, 2007). Incorpor-
atingsuchspatialconsiderationsintoaquantitativemodelwill
be a major challenge for the future studies.
Otherregulatorymechanismscould alsocontributetoorder.
Functional dependency (Hartwell et al, 1974) and intrinsic
process duration (e.g. the time it takes to build a new spindle
pole body) could provide effective cell cycle ordering,
especially when reinforced by checkpoints for occasional
process failure (Hartwell and Weinert, 1989). It has recently
been shown that transcriptional oscillation (Orlando et al,
2008) and cyclical centrosome duplication (McCleland and
O’Farrell, 2008) can occur independently of cyclin–Cdk
oscillation.
These repeated Cdk-independent oscillations could be inte-
grally involved in cell cycle timing, provided the intrinsic freq-
uency of these independent oscillators is close to the cyclin–
Cdk oscillator frequency, and assuming some mechanism(s)
for occasional modulation of the phase of these oscillators by
cyclin–Cdk activity. In any case, cyclin–Cdk-independent
oscillation of cell cycle events suggests the possibility of
intrinsic ‘momentum’ of cell cycle events, in the face of ﬁxed
cyclin–Cdk levels, consistent with the results reported here.
Materials and methods
Loading undegradable mitotic cyclin into
pre-anaphase cells
CLB2HGAL1-CLB2Ddb,ken1,2-YFP ADH1pr-GAL4-rMR cdc20HMET3-
HA3-CDC20 cells, grown in rafﬁnose medium lacking methionine,
were incubated for 150min in 2mM methionine to turn off MET3-
CDC20 and induce a metaphase block. Clb2kd–YFP was induced
for 30min in 10mM deoxycorticosterone; subsequently, 45min in
glucoseþmethionine allowed maturation of Clb2–YFP ﬂuorescence.
Methionine removal turned on MET3-CDC20 and released the
metaphase block. Re-addition of methionine after 45min collected
cells at a second metaphase block.
Quantitative ﬂuorescence microscopy
Cells were lightly ﬁxed in 4% paraformaldehyde. YFP ﬂuorescence
was quantiﬁed from single unenhanced exposures, after single-cell
masking and background subtraction. For analysis of spindles,
cytokinesis rings and buds, 3–5 0.3-mm, contrast-enhanced optical
sections were combined. These procedures yielded single-cell correla-
tions between Clb2kd–YFP levels and mitotic exit phenotypes. Cdc14–
Net1 colocalization was measured essentially as described by Lu and
Cross (2009), using the coefﬁcient of variation (CV; s.d. divided by
mean) of Cdc14–YFP signal over the cell, divided by the CVof Net1–
mCherry. CV decreases as signal spreads through the cell. The use of
the CVratio standardizes apparent dispersal of Cdc14 to that of Net1,
controllingforchangesinfocalplaneorNet1/nucleolarmorphological
variations.
Population Clb2kd–YFP measurement
by immunoblot
Clb2–YFP 60-min peak and Clb2kd–YFP pulse samples were serially
diluted two-fold into clb2D extract for calibration. Blots were probed
with anti-GFP (Roche), anti-Clb2, and anti-Pgk1 (Santa Cruz Biotech-
nology) (loading control). ECL signal was imaged using a Fujiﬁlm
DarkBoxþCCD camera and quantiﬁed using MultiGauge (Fujiﬁlm)
software (linear detection range). Multiple comparisons were
performed for each time point.
Clb2kd inhibitory threshold calculation
Inhibitory thresholds were measured at different time points after
event completion in the unpulsed control. The percentage of Clb2kd
peak-equivalence (%peak) was determined by:
%Peak ¼
FCell
meanFCell
 
WPulse
WPeak
where Fcell is the YFP ﬂuorescence of an individual pulsed cell; Wpulse
the quantiﬁed anti-YFP immunoblot signal from the pulsed popula-
tion; Wpeak the quantiﬁed anti-YFP immunoblot signal from peak
synchronized wild-type samples.
Cells were sorted into Clb2kd-YFP bins containing 460 cells, and
phenotypes of cells in these bins yielded inhibitory Clb2kd concentra-
tions (Figure 1C).
ODE modeling
An implementation of the Chen et al. (2004) model in MatLab was
modiﬁed to model precisely the cdc20 block-release protocol used in
these experiments; this model was used for testing the previous and
variantmodelsformodeledbiologicalandbiochemicalresponses.The
code can be made available on request (fcross@mail.rockefeller.edu).
Additional information on methods and strain list can be found in
Supplementary materials.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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